Capricor Therapeutics | CAPR - Current Assets


Capricor Therapeutics reported $100.95M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Alterity Therapeutics Limited AUD 27.05M 6.16M Jun/2023
Bioline Rx USD 28.52M 3.34M Sep/2025
Capricor Therapeutics USD 100.95M 23.18M Sep/2025
Cipla INR 249.18B 16.3B Sep/2025
Cytokinetics USD 916.97M 60.37M Dec/2025
Geron USD 520.27M 2.07M Dec/2025
Grifols EUR 6.28B 92.48M Sep/2025
Immunic USD 39.27M 20.57M Sep/2025
J&J USD 55.62B 1.01B Dec/2025
Plus Therapeutics USD 9.83M 1.75M Dec/2023
Prothena USD 339.97M 45.51M Sep/2025
PTC Therapeutics USD 2.27B 266.14M Dec/2025
Sarepta Therapeutics USD 2.54B 184.37M Dec/2025